SydLab™ ONE
unlocking Organism-on-Chip testing to any lab
the first fully automated high-content screening system on C. elegans to speed-up and de-risk your research and discovery efforts
Throughput
64 independent conditions tested on 1000+ organisms in parallel per experiment.
Cost-saving
20x less manual work, no need of trained staff, and 10x less compound consumption.
Fast
Average time-to-result of 7 days, up to 40x faster than mice testing.
Smart Data
Real-time data extraction, visualization, and AI-based analysis of +25 datapoints/hour/organism.
explore the full solution
SydLab™ ONE
obtain your data in just 4 simple steps
The sydlab™ one experience
datapoints like never before
Get quick and accurate data about the effects of your compounds on living systems. Make predictions about their potential impact on animal and human health.
the trusted partner of researchers
-
Failure in later stages of the R&D pipeline is especially costly. We actively pursue technologies to identify adverse toxicology as early as possible, such as Nagi Bioscience’s technologies.
Early Toxicology Safety – Agrochemical Company
Unfavorable toxicological profiles are a major cause of late failure in our discovery pipelines. Failure in later stages of the R&D pipeline is especially costly. We are actively pursuing technologies to identify adverse toxicology as early as possible, including through the use of model systems such as those being investigated by Nagi Bioscience.
Early Toxicology Safety – Agrochemical Company
-
Methodologies to assess lifespan and healthspan measures in a high-throughput manner are currently inadequate in the C. elegans field. The integration of Nagi’s technology opened many possibilities for us as a company.
CEO – Aging Biotech Company
Before proceeding to clinical trials, the efficacy of our existing drugs or combinations thereof for their positive impact on healthspan will be tested in the nematode C.elegans. However, methodologies to assess lifespan and healthspan measures in a high-throughput manner are currently inadequate in the C. elegans field. The integration of Nagi’s technology into Rejuvenate opened many possibilities for us as a company.
CEO – Aging Biotech Company
welcome to the sydlab™ one universe
